Gene · 6554
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hepatitis B Viral Protein HBx and the Molecular Mechanisms Modulating the Hallmarks of Hepatocellular Carcinoma: A Comprehensive Review. | Cells | 2022 | 35203390 | PubTator, text mining | PubMed |
| NTCP polymorphisms were associated with fibrosis development in patients with chronic HBV infection. | J Infect Dev Ctries | 2022 | 35192536 | PubTator, text mining | PubMed |
| The role of circadian clock pathways in viral replication. | Semin Immunopathol | 2022 | 35192001 | PubTator, text mining | PubMed |
| Human/SARS-CoV-2 genome-scale metabolic modeling to discover potential antiviral targets for COVID-19. | J Taiwan Inst Chem Eng | 2022 | 35186172 | PubTator, text mining | PubMed |
| The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease. | Front Immunol | 2022 | 35185922 | PubTator, text mining | PubMed |
| Gene Expression Profiling of 1α,25(OH)2 D3 Treatment in 2D/3D Human Hepatocyte Models Reveals CYP3A4 Induction but Minor Changes in Other Xenobiotic-Metabolizing Genes. | Mol Nutr Food Res | 2022 | 35184385 | PubTator, text mining | PubMed |
| Lipid raft-mediated and upregulated coordination pathways assist transport of glycocholic acid-modified nanoparticle in a human breast cancer cell line of SK-BR-3. | Int J Pharm | 2022 | 35176336 | PubTator, text mining | PubMed |
| Evodiamine decreased the systemic exposure of pravastatin in non-alcoholic steatohepatitis rats due to the up-regulation of hepatic OATPs. | Pharm Biol | 2022 | 35171063 | PubTator, text mining | PubMed |
| Adaptive Mechanisms of Renal Bile Acid Transporters in a Rat Model of Carbon Tetrachloride-Induced Liver Cirrhosis. | J Clin Med | 2022 | 35160088 | PubTator, text mining | PubMed |
| Evidence of Adult Features and Functions of Hepatocytes Differentiated from Human Induced Pluripotent Stem Cells and Self-Organized as Organoids. | Cells | 2022 | 35159346 | PubTator, text mining | PubMed |
| Drug Disposition Protein Quantification in Matched Human Jejunum and Liver From Donors With Obesity. | Clin Pharmacol Ther | 2022 | 35158408 | PubTator, text mining | PubMed |
| A Case of Infantile Alagille Syndrome With Severe Dyslipidemia: New Insight into Lipid Metabolism and Therapeutics. | J Endocr Soc | 2022 | 35155971 | PubTator, text mining | PubMed |
| Inducers of the NF-κB pathways impair hepatitis delta virus replication and strongly decrease progeny infectivity in vitro. | JHEP Rep | 2022 | 35141510 | PubTator, text mining | PubMed |
| High mobility group AT-hook 1 (HMGA1) is an important positive regulator of hepatitis B virus (HBV) that is reciprocally upregulated by HBV X protein. | Nucleic Acids Res | 2022 | 35137191 | PubTator, text mining | PubMed |
| Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir. | Biomed Pharmacother | 2022 | 35131656 | PubTator, text mining | PubMed |
| Interruption of bile acid uptake by hepatocytes after acetaminophen overdose ameliorates hepatotoxicity. | J Hepatol | 2022 | 35131407 | PubTator, text mining | PubMed |
| MRP5 and MRP9 play a concerted role in male reproduction and mitochondrial function. | Proc Natl Acad Sci U S A | 2022 | 35121660 | PubTator, text mining | PubMed |
| Advances in new antivirals for chronic hepatitis B. | Chin Med J (Engl) | 2022 | 35120358 | PubTator, text mining | PubMed |
| Chronic hepatitis B: New potential therapeutic drugs target. | World J Virol | 2022 | 35117971 | PubTator, text mining | PubMed |
| mPEG-Cholic acid/TPGS mixed micelles for combined delivery of paclitaxel and bufalin to treat hepatocellular carcinoma. | Pharm Dev Technol | 2022 | 35105263 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6554/papers?page=46